此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Effects of Whole-Body Vibration on Heart Rate Variability During Post-Exercise Recovery (WBV-HRV)

2026年11月6日 更新者:Hamza Budak

Effects of Whole-Body Vibration Versus Passive Recovery on Frequency-Domain Heart Rate Variability Following High-Intensity Exercise: A Randomized Crossover Trial

This study aims to investigate the acute effects of whole-body vibration (WBV) and passive recovery on heart rate variability (HRV) following high-intensity intermittent exercise in male soccer players.

Ten male soccer players will participate in a randomized, two-period crossover study. Each participant will complete two experimental sessions separated by a seven-day washout period. During each session, participants will perform the Yo-Yo Intermittent Recovery Test Level 1 until exhaustion, followed by either 15 minutes of seated whole-body vibration or 15 minutes of seated passive recovery.

During the WBV condition, participants will remain seated with their knees flexed at approximately 90 degrees and their bare feet positioned on a vibration platform operating at 35 Hz with a peak-to-peak amplitude of 2 mm. During passive recovery, participants will remain seated without vibration.

Heart rate variability will be continuously recorded throughout the exercise test and the entire 15-minute recovery period using a chest-strap heart rate sensor. Frequency-domain HRV parameters, including very-low-frequency (VLF), low-frequency (LF), and high-frequency (HF) power, will be analyzed.

The study will compare the autonomic responses associated with the two recovery methods to determine whether seated whole-body vibration produces different short-term HRV responses compared with passive recovery.

研究概览

详细说明

This study is designed as a randomized, two-period crossover trial to examine the acute effects of whole-body vibration (WBV) and passive recovery on frequency-domain heart rate variability (HRV) following exhaustive intermittent exercise.

Ten male soccer players will participate in the study. Participants will be randomly assigned to one of two intervention sequences: WBV followed by passive recovery (AB) or passive recovery followed by WBV (BA). A seven-day washout period will separate the experimental sessions to minimize potential carryover effects.

At each experimental session, participants will complete the Yo-Yo Intermittent Recovery Test Level 1 until voluntary exhaustion. Following exercise, participants will undergo a 15-minute recovery intervention according to their assigned sequence.

During the WBV intervention, participants will sit on a chair with their knees flexed at approximately 90 degrees and their bare feet placed on a vertical vibration platform operating at 35 Hz with a peak-to-peak displacement of 2 mm. During the passive recovery intervention, participants will remain seated in a comparable position with their feet resting on the floor and without vibration exposure.

Heart rate variability will be recorded continuously throughout the exercise test and the complete 15-minute recovery period using a Polar H10 chest-strap sensor. HRV data will be processed using Kubios HRV software to obtain frequency-domain parameters, including VLF, LF, and HF power.

The primary objective is to compare frequency-domain HRV responses between WBV and passive recovery conditions. Statistical analyses will account for the paired crossover design and evaluate differences between recovery conditions.

The findings are expected to contribute to the understanding of acute autonomic responses to whole-body vibration as a post-exercise recovery intervention in soccer players.

研究类型

介入性

注册 (估计的)

10

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 40年 (成人)

接受健康志愿者

是的

有资格学习的性别

男性

描述

Inclusion Criteria:

  • Male soccer players within the predefined eligible age range.
  • Regular participation in soccer training.
  • Ability to complete the Yo-Yo Intermittent Recovery Test Level 1.
  • Willingness to participate in both experimental sessions.
  • Provision of written informed consent.

Exclusion Criteria:

  • Known cardiovascular, neurological, or musculoskeletal disorders that could affect exercise performance or heart rate variability.
  • Current injury or illness preventing maximal exercise.
  • Use of medications known to influence autonomic nervous system activity or heart rate variability.
  • Any contraindication to whole-body vibration exposure.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:交叉作业
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Sequence AB (WBV → Passive Recovery)

Participants assigned to Sequence AB will undergo whole-body vibration (WBV) recovery during the first experimental period, followed by passive recovery during the second period. A seven-day washout period will separate the two sessions. Both recovery interventions will last 15 minutes and will be performed in a seated position following the Yo-Yo Intermittent Recovery Test Level 1. During WBV recovery, participants will remain seated with their feet placed on the vibration platform, operating at 35 Hz and 2 mm peak-to-peak amplitude.

Participants assigned to the whole-body vibration (WBV) intervention will undergo a 15-minute recovery session immediately following the Yo-Yo Intermittent Recovery Test Level 1. During the intervention, participants will remain seated on a chair with their knees flexed at approximately 90 degrees and their bare feet placed on a vertical vibration platform. The platform will operate at a frequency of 35 Hz and a peak-to-peak amplitude of 2 mm. Heart rate variability will be continuously recorded throughout the 15-minute recovery period to evaluate autonomic nervous system responses.

Participants assigned to the passive recovery intervention will undergo a 15-minute seated recovery session immediately following the Yo-Yo Intermittent Recovery Test Level 1. During this period, participants will remain seated on a chair with their feet resting on the floor, without receiving whole-body vibration or any other active recovery intervention. Heart rate variability will be continuously recorded throughout the 15-minute recovery period to evaluate autonomic nervous system responses.

实验性的:Sequence BA (Passive Recovery → WBV)

Participants assigned to Sequence BA will undergo passive recovery during the first experimental period, followed by whole-body vibration (WBV) recovery during the second period. A seven-day washout period will separate the two sessions. Both recovery interventions will last 15 minutes and will be performed in a seated position following the Yo-Yo Intermittent Recovery Test Level 1. During passive recovery, participants will remain seated with their feet resting on the floor. During WBV recovery, participants will remain seated with their feet placed on the vibration platform, operating at 35 Hz and 2 mm peak-to-peak amplitude.

Participants assigned to the whole-body vibration (WBV) intervention will undergo a 15-minute recovery session immediately following the Yo-Yo Intermittent Recovery Test Level 1. During the intervention, participants will remain seated on a chair with their knees flexed at approximately 90 degrees and their bare feet placed on a vertical vibration platform. The platform will operate at a frequency of 35 Hz and a peak-to-peak amplitude of 2 mm. Heart rate variability will be continuously recorded throughout the 15-minute recovery period to evaluate autonomic nervous system responses.

Participants assigned to the passive recovery intervention will undergo a 15-minute seated recovery session immediately following the Yo-Yo Intermittent Recovery Test Level 1. During this period, participants will remain seated on a chair with their feet resting on the floor, without receiving whole-body vibration or any other active recovery intervention. Heart rate variability will be continuously recorded throughout the 15-minute recovery period to evaluate autonomic nervous system responses.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Very Low Frequency (VLF) Power
大体时间:During the exercise test and the subsequent 15-minute recovery period in each experimental session.

Very low frequency (VLF) power is a frequency-domain parameter of heart rate variability (HRV), expressed in ms². HRV will be continuously recorded using a Polar H10 chest strap during the entire exercise test and the 15-minute recovery period. VLF power will be analyzed using Kubios HRV software to assess autonomic responses under whole-body vibration and passive recovery conditions.

During the exercise test and the subsequent 15-minute recovery period in each experimental session.
Low Frequency (LF) Power
大体时间:During the exercise test and the subsequent 15-minute recovery period in each experimental session.

Low frequency (LF) power is a frequency-domain parameter of heart rate variability (HRV), expressed in ms². HRV will be continuously recorded using a Polar H10 chest strap during the entire exercise test and the 15-minute recovery period. LF power will be analyzed using Kubios HRV software to evaluate autonomic responses under whole-body vibration and passive recovery conditions.

During the exercise test and the subsequent 15-minute recovery period in each experimental session.
High Frequency (HF) Power
大体时间:During the exercise test and the subsequent 15-minute recovery period in each experimental session.

High frequency (HF) power is a frequency-domain parameter of heart rate variability (HRV), expressed in ms², and is commonly used as an indicator of cardiac parasympathetic modulation. HRV will be continuously recorded using a Polar H10 chest strap during the entire exercise test and the 15-minute recovery period. HF power will be analyzed using Kubios HRV software to compare responses between whole-body vibration and passive recovery conditions.

During the exercise test and the subsequent 15-minute recovery period in each experimental session.

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

赞助

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年11月17日

初级完成 (估计的)

2026年11月24日

研究完成 (估计的)

2026年11月24日

研究注册日期

首次提交

2026年11月6日

首先提交符合 QC 标准的

2026年11月6日

首次发布 (实际的)

2026年11月12日

研究记录更新

最后更新发布 (实际的)

2026年11月12日

上次提交的符合 QC 标准的更新

2026年11月6日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

IPD 计划说明

Individual participant data will not be made publicly available due to participant confidentiality and data protection considerations. Only aggregated and anonymized study results will be reported in scientific publications.

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅